YWHAE and endometrioid stromal sarcoma: HG-ESS was recognized as a distinct entity characterized by round-cell morphology and associated genetic alterations, particularly YWHAE-NUTM2 fusions, while LG-ESS and HG-ESS account for approximately 86% and 14% of endometrial stromal sarcomas, respectively [6,7,8].